Healthcare provider profile · identity verified

Stephen J Kushner, DO

Family Practice · HOCKESSIN, DE · NPI 1134104805

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	589	182
Amlodipine Besylate	Amlodipine Besylate	547	151
Atorvastatin Calcium	Atorvastatin Calcium	464	146
Escitalopram Oxalate	Escitalopram Oxalate	402	131
Hydrochlorothiazide	Hydrochlorothiazide	341	96
Levothyroxine Sodium	Levothyroxine Sodium	338	93
Lisinopril	Lisinopril	338	92
Simvastatin	Simvastatin	324	88
Omeprazole	Omeprazole	279	78
Olmesartan Medoxomil	Olmesartan Medoxomil	216	57
Metformin Hcl	Metformin Hcl	212	61
Losartan Potassium	Losartan Potassium	185	51
Alprazolam	Alprazolam	171	40
Metoprolol Succinate	Metoprolol Succinate	145	42
Metformin Hcl Er	Metformin Hcl	144	51
Meloxicam	Meloxicam	140	48
Tamsulosin Hcl	Tamsulosin Hcl	134	39
Bupropion Xl	Bupropion Hcl	115	35
Albuterol Sulfate Hfa	Albuterol Sulfate	111	63
Gabapentin	Gabapentin	110	37
Montelukast Sodium	Montelukast Sodium	108	29
Ozempic	Semaglutide	106	26
Jardiance	Empagliflozin	103	25
Allopurinol	Allopurinol	100	28
Farxiga	Dapagliflozin Propanediol	95	23
Pantoprazole Sodium	Pantoprazole Sodium	92	34
Eliquis	Apixaban	90	25
Potassium Chloride	Potassium Chloride	89	27
Synthroid	Levothyroxine Sodium	85	24
Fluticasone Propionate	Fluticasone Propionate	81	39
Sertraline Hcl	Sertraline Hcl	73	27
Azithromycin	Azithromycin	66	57
Fluoxetine Hcl	Fluoxetine Hcl	66	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	66	17
Chlorthalidone	Chlorthalidone	62	19
Zolpidem Tartrate	Zolpidem Tartrate	62	22
Carvedilol	Carvedilol	61	18
Citalopram Hbr	Citalopram Hydrobromide	58	19
Candesartan Cilexetil	Candesartan Cilexetil	56	18
Hydroxyzine Hcl	Hydroxyzine Hcl	53	20
Pravastatin Sodium	Pravastatin Sodium	53	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	51	44
Alendronate Sodium	Alendronate Sodium	50	16
Glipizide Er	Glipizide	49	13
Paroxetine Hcl	Paroxetine Hcl	49	12
Trazodone Hcl	Trazodone Hcl	49	12
Atenolol	Atenolol	48	16
Furosemide	Furosemide	47	14
Metoprolol Tartrate	Metoprolol Tartrate	46	12
Januvia	Sitagliptin Phosphate	44	12
Methylprednisolone	Methylprednisolone	44	40
Ezetimibe	Ezetimibe	43	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	42	14
Irbesartan	Irbesartan	41	12
Clonazepam	Clonazepam	40	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	12
Glipizide	Glipizide	39	suppressed
Xarelto	Rivaroxaban	39	suppressed
Clopidogrel	Clopidogrel Bisulfate	35	13
Mirtazapine	Mirtazapine	35	11
Esomeprazole Magnesium	Esomeprazole Magnesium	34	suppressed
Valacyclovir	Valacyclovir Hcl	34	19
Valsartan	Valsartan	33	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	32	suppressed
Lorazepam	Lorazepam	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	20
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Celecoxib	Celecoxib	27	suppressed
Cephalexin	Cephalexin	27	20
Diazepam	Diazepam	27	suppressed
Topiramate	Topiramate	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	26	17
Buspirone Hcl	Buspirone Hcl	25	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Duloxetine Hcl	Duloxetine Hcl	22	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Famotidine	Famotidine	19	suppressed
Fluconazole	Fluconazole	18	14
Levetiracetam	Levetiracetam	18	suppressed
Midodrine Hcl	Midodrine Hcl	18	suppressed
Nystatin	Nystatin	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Prednisone	Prednisone	15	12
Glyburide	Glyburide	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Temazepam	Temazepam	14	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Emtricitabine-Tenofovir Disop	Emtricitabine/Tenofovir (Tdf)	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	13
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Pulmicort Flexhaler	Budesonide	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Alprazolam Er	Alprazolam	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Naproxen Sodium	Naproxen Sodium	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error